As European markets navigate the complexities of trade deals and economic stagnation, investors are increasingly looking towards dividend stocks as a potential source of stability and income. In such an environment, selecting stocks that offer consistent dividend payouts can provide a reliable stream of income while potentially enhancing portfolio resilience amidst market fluctuations. Top 10 Dividend Stocks In Europe Name Dividend Yield Dividend Rating Zurich Insurance Group (SWX:ZURN) 4.49% ★★★★★★ Rubis (ENXTPA:RUI) 7.39% ★★★★★★ OVB Holding (XTRA:O4B) 4.59% ★★★★★★ Holcim (SWX:HOLN) 4.77% ★★★★★★ HEXPOL (OM:HPOL B) 5.08% ★★★★★★ DKSH Holding (SWX:DKSH) 4.15% ★★★★★★ Deutsche Post (XTRA:DHL) 4.83% ★★★★★★ Cembra Money Bank (SWX:CMBN) 4.65% ★★★★★★ Banque Cantonale Vaudoise (SWX:BCVN) 4.67% ★★★★★★ Allianz (XTRA:ALV) 4.61% ★★★★★★ Click here to see the full list of 222 stocks from our Top European Dividend Stocks screener. Let's review some notable picks from our screened stocks. CaixaBank Simply Wall St Dividend Rating: ★★★★★☆ Overview: CaixaBank, S.A. offers a range of banking products and financial services both in Spain and internationally, with a market capitalization of approximately €57.35 billion. Operations: CaixaBank's revenue segments include the Portuguese Investment Bank (BPI) which contributes €1.15 billion. Dividend Yield: 7.1% CaixaBank's dividend yield of 7.06% places it among the top 25% in Spain, supported by a reasonable payout ratio of 53.1%. Despite past volatility in dividends, earnings growth and coverage forecasts suggest sustainability. Recent earnings showed mixed results with a six-month net income increase to €2.95 billion, though quarterly figures declined year-on-year. The bank's interest in acquiring Novo Banco highlights strategic expansion ambitions amidst regulatory challenges in cross-border banking deals within Europe. Navigate through the intricacies of CaixaBank with our comprehensive dividend report here. Upon reviewing our latest valuation report, CaixaBank's share price might be too pessimistic.BME:CABK Dividend History as at Aug 2025 Clínica Baviera Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Clínica Baviera, S.A. is a medical company that operates a network of ophthalmology clinics across Spain and Europe, with a market cap of €710.65 million. Operations: Clínica Baviera, S.A. generates its revenue through a network of ophthalmology clinics located in Spain and Europe. Dividend Yield: 3.5% Clínica Baviera's dividend payments are covered by earnings and cash flows, with payout ratios of 64.3% and 60%, respectively, though the dividends have been volatile over the past decade. The company's recent half-year earnings show a slight decline in net income to €22.32 million despite increased sales of €156.11 million. With a P/E ratio of 18.2x below the industry average, it offers value but has a lower-than-top-tier dividend yield at 3.54%. Story Continues Click here and access our complete dividend analysis report to understand the dynamics of Clínica Baviera. Insights from our recent valuation report point to the potential overvaluation of Clínica Baviera shares in the market.BME:CBAV Dividend History as at Aug 2025 Corticeira Amorim S.G.P.S Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Corticeira Amorim S.G.P.S. specializes in acquiring and transforming cork into a range of products across Europe, the United States, Rest of America, Australasia, and Africa, with a market cap of €1.04 billion. Operations: Corticeira Amorim S.G.P.S. generates revenue primarily from its Amorim Cork segment, which contributes €734.20 million, and its Amorim Florestal segment, which adds €226.33 million. Dividend Yield: 5.3% Corticeira Amorim's dividends are supported by earnings and cash flows, with payout ratios of 60.8% and 50.4%, respectively, despite a history of volatility over the past decade. Recent half-year results showed stable net income at €36.8 million on slightly decreased sales of €473.1 million compared to last year. The annual dividend increased to €0.32 per share in May 2025, but its yield remains below the top tier in Portugal at 5.26%. Dive into the specifics of Corticeira Amorim S.G.P.S here with our thorough dividend report. Insights from our recent valuation report point to the potential undervaluation of Corticeira Amorim S.G.P.S shares in the market.ENXTLS:COR Dividend History as at Aug 2025 Seize The Opportunity Dive into all 222 of the Top European Dividend Stocks we have identified here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world. Interested In Other Possibilities? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BME:CABK BME:CBAV and ENXTLS:COR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
European Dividend Stocks To Enhance Your Portfolio
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...